MHRA company-led drug alert – Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

MHRA company-led drug alert – Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

June 25, 2018

CLDA number: CLDA (18)A/03

Date issued: 25th June 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for certain batches of:

Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd)

PL number: PL04483/0071

Britannia Pharmaceuticals Ltd is recalling certain batches of the above because of increased crystallisation of the active ingredient which may affect the delivery of the full dose.

To view the alert please visit the GOV.UK website.



Posted in:


More Latest News >

EPS Phase 4 piloting

NHS Digital continues to pilot EPS Phase 4. All pharmacy staff need to be aware that they could receive a...

PSNC Job Opportunity: Office Administrator

PSNC (the Pharmaceutical Services Negotiating Committee) represents England’s community (high-street) pharmacies, and is looking to recruit an Office Administrator to...